Daewoong Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Daewoong Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Daewoong Pharmaceutical Co Ltd Strategy Report
- Understand Daewoong Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Daewoong Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US11433054B2 | Grant | Pharmaceutical preparation and preparation method therefor | A61K31/426; A61K47/02; A61K47/12; A61K47/34; A61K47/38; A61K9/2095; A61K9/2893; A61K9/5089 | September 06, 2022 |
AU2021225706A1 | Application | Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same | A61K31/343; C07B2200/13; C07D307/82; C07H1/02; C07H17/04; Y02P20/55 | September 01, 2022 |
CA3084777C | Grant | AMINO-FLUOROPIPERIDINE DERIVATIVES AS KINASE INHIBITOR | A61K31/519; A61P35/00; A61P37/00; C07D487/04 | August 30, 2022 |
CO2022011593A2 | Application | Método de preparación de derivados de amina heterocíclica | A61K31/5377; C07D417/14 | August 30, 2022 |
CO2022011686A2 | Application | Intermedio útil para la síntesis de un inhibidor de sglt y método para preparar un inhibidor de sglt utilizando el mismo | A61K31/343; C07B2200/13; C07D307/82; C07H1/02; C07H17/04; Y02P20/55 | August 30, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer